MicroScan autoSCAN-4 System
Standardized ID/AST testing made simple
Receive your quote directly from the manufacturer.
Provides great MIC results, true MICs.
Antimicrobial susceptibility testing
The Microscan Autoscan is great instrumentation to have to produce accurate and reliable MICs in antimicrobial susceptibility testing. It is easy to use and costs less to maintain. It s a must-have in any clinical laboratory.
Review Date: 3 May 2022 | Beckman Coulter Diagnostics
SIMPLIFIES ID/AST TESTING WHILE PROVIDING STANDARDIZED RESULTS
The MicroScan autoSCAN-4 System provides accurate and reliable bacterial identification and susceptibility evaluation. The autoSCAN-4 System processes panels in seconds, simplifying identification and antibiotic susceptibility testing (ID/AST) while standardizing results.
MicroScan autoSCAN-4 Product Features:
STREAMLINES WORKFLOW
- Incubate panels off-line and load on the autoSCAN-4 System
- Computerized system automatically records and interprets instrument results
- On-line edit feature allows for user intervention, if indicated, after visual read
- Choice of inoculating methods to fit your workflow
- Added confidence in knowing you can visually confirm atypical results
- Automated processing assures consistency
ENHANCED FEATURES COME STANDARD
- Sophisticated informatics package of LabPro with AlertEX is a standard feature
- On-site installation and training support by Microbiology and System Specialists
ZERO IN ON EMERGING RESISTANCE
- Comprehensive, up-to-date selection of antimicrobial agents
- Multiple antimicrobics tested per panel for broad and cost-effective reporting
- Direct MIC results independent of organism identification
- Combo panels provide ID and MIC results on a single panel
- ID-only and MIC-only panel selections balance your workload needs
- Full MIC and breakpoint antimicrobic dilution configurations available
- Extensive Gram Negative, Gram Positive, and fastidious organism identification database
Improving diagnosis of sepsis with early recognition of AMR
Post-pandemic, hospital-onset infections from resistant pathogens have surged, with significant increases in carbapenem-resistant, ESßL-producing, and multidrug-resistant infections. Antimicrobial resistance (AMR) and its impact on sepsis, a condition affecting 49 million people and causing 11 million deaths annually, urgently needs to be addressed. Download this resource to discover how Beckman Coulter’s MicroScan systems provide accurate, timely resistance detection, supporting better antimicrobial therapy decisions to combat this costly and deadly condition.
Beckman Coulter launches one of the first high-quality, high-throughput COVID-19 antigen test ideal for mass testing in the U.S.
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable
